The entire lifecycle of a Menghini liver biopsy needle, from raw material receiving to sterile packaging and shipment, involves far more than simple processing and assembly. At Manners Technology, every procedure adheres to ISO 13485:2016 (Medical Devices Quality Management System) and ISO 9001:2015, embodying the relentless pursuit of safety, efficacy and consistent performance. This integrated framework forms a comprehensive quality assurance network covering the full product lifecycle, guaranteeing every needle is reliable enough for clinical use on patients.

Phase 1: Risk-Driven Design and Development

Quality originates from design. When undertaking customized Menghini needle projects or optimizing existing products, Manners Technology initiates the workflow with systematic risk analysis. Engineers and quality teams jointly conduct thorough assessments: whether the bevel angle delivers sufficient sharpness while eliminating risks of unintended penetration caused by overly sharp tips; whether the wall thickness maintains structural rigidity with minimized outer diameter to reduce tissue trauma; and whether selected materials remain stable under all anticipated service conditions.

All analysis results are converted into definitive design input requirements. Design verification (to confirm outputs comply with inputs) and design validation (to verify conformance with clinical requirements via simulation and testing) are implemented to close the quality loop.

Phase 2: Traceable Supply Chain and Material Control

The commitment to providing full BOM material certificates is fully actionable. Every batch of stainless steel bar stock for production is accompanied by traceable Material Test Certificates (MTC), including chemical composition analysis and mechanical property reports. All suppliers undergo rigorous qualification audits. After incoming inspection, raw materials are properly labelled and stored in designated zones, with random sampling conducted on a regular basis. Such source control lays a solid foundation for overall product reliability.

Phase 3: Controlled Manufacturing and Process Validation

Production is fully transparent with no unmonitored procedures. All critical manufacturing processes at Manners Technology are validated and subject to stringent in-process control:

• 5-axis laser cutting: Parameters including laser power, cutting speed and assist gas pressure are clearly defined and fully documented.
• Electropolishing: Electrolyte composition, temperature, current density and processing duration are precisely controlled, with solution conditions monitored periodically.
• Ultrasonic cleaning: Standard operating procedures govern detergent concentration, temperature, ultrasonic frequency and cleaning duration.
• These process parameters are closely correlated with critical quality characteristics such as dimensional accuracy, surface finish and cleanliness. Statistical Process Control (SPC) is applied to sustain stable and controlled production, ensuring consistent output of qualified products.

Phase 4: Comprehensive Inspection and Testing

Products must pass multiple strict checkpoints before release:

• Incoming Quality Control (IQC): Verification of all raw materials.
• In-Process Quality Control (IPQC): Random inspections during production, e.g., visual check of needle tip geometry after laser cutting.
• Final Quality Control / Outgoing Quality Control (FQC/OQC): 100% full inspection or AQL sampling inspection for finished products, covering:

    Dimensional measurement: Precision testing of length, diameter, angle and other specifications.

    Visual inspection: Examination under magnifiers for scratches, burrs and contaminants.

    Functional testing: Simulated negative pressure testing to verify lumen patency and airtightness of connections.

    Performance testing: Penetration force test, needle tip sharpness test and other relevant assessments.

• Packaging and sterilization validation: Final packaging and sterilization processes (e.g., ethylene oxide sterilization) undergo strict validation to confirm effective microbial elimination and sustained sterility throughout the product shelf life.

Phase 5: Continuous Improvement and Adverse Event Surveillance

The ISO 13485 system mandates a formal Corrective and Preventive Action (CAPA) procedure. Any non-conforming products identified internally or feedback received from customers will be systematically investigated to identify root causes, with targeted measures implemented to prevent recurrence.

In addition, a post-market vigilance system is established to monitor, report and evaluate adverse events related to commercialized products, forming a closed loop from market feedback to design enhancement.

Conclusion

What Manners Technology delivers is not merely Menghini liver biopsy needles, but a complete, transparent and fully traceable quality assurance system. Upholding the philosophy that quality is built into products rather than merely inspected after production, the ISO 13485-based management minimizes human errors via standardized procedures, complete documentation and data-driven supervision. Every needle supplied to the market stands for a solemn commitment to patient safety and optimal clinical outcomes.